These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31887854)

  • 21. Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer's disease: a meta-analysis.
    Su J; Liu Y; Liu Y; Ren L
    Expert Rev Neurother; 2015; 15(9):1093-103. PubMed ID: 26289489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of brain training on brain blood flow (The Cognition and Flow Study-CogFlowS): protocol for a feasibility randomised controlled trial of cognitive training in dementia.
    Beishon L; Evley R; Panerai RB; Subramaniam H; Mukaetova-Ladinska E; Robinson T; Haunton V
    BMJ Open; 2019 May; 9(5):e027817. PubMed ID: 31122994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.
    Nieto RA; Deardorff WJ; Grossberg GT
    Expert Opin Pharmacother; 2016; 17(6):861-70. PubMed ID: 26918774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
    Feldman HH; Ferris S; Winblad B; Sfikas N; Mancione L; He Y; Tekin S; Burns A; Cummings J; del Ser T; Inzitari D; Orgogozo JM; Sauer H; Scheltens P; Scarpini E; Herrmann N; Farlow M; Potkin S; Charles HC; Fox NC; Lane R
    Lancet Neurol; 2007 Jun; 6(6):501-12. PubMed ID: 17509485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Subjective cognitive impairment and Alzheimer's disease: a two year follow up of 51 subjects during two years].
    Sambuchi N; Muraccioli I; Alescio-Lautier B; Paban V; Sambuc R; Jouve É; Geda YE; Petersen RK; Michel BF
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Dec; 13(4):462-71. PubMed ID: 26707564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rivastigmine for Alzheimer's disease.
    Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivastigmine transdermal patch and physical exercises for Alzheimer's disease: a randomized clinical trial.
    Aguiar P; Monteiro L; Feres A; Gomes I; Melo A
    Curr Alzheimer Res; 2014; 11(6):532-7. PubMed ID: 24938502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
    Touchon J; Bergman H; Bullock R; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Lasting Neuropsychological Effects of a Computerized Cognitive Training in Patients Affected by Early Stage Alzheimer's Disease: Are They Stable Over Time?
    Cavallo M; Angilletta C
    J Appl Gerontol; 2019 Jul; 38(7):1035-1044. PubMed ID: 29295652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
    Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
    Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.
    Almkvist O; Darreh-Shori T; Stefanova E; Spiegel R; Nordberg A
    Eur J Neurol; 2004 Apr; 11(4):253-61. PubMed ID: 15061827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training.
    Karran M; Guerrero-Berroa E; Schmeidler J; Lee PG; Alexander N; Nabozny M; West RK; Beeri MS; Sano M; Silverman JM
    J Alzheimers Dis; 2019; 69(2):401-411. PubMed ID: 31006684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
    Wolfson C; Oremus M; Shukla V; Momoli F; Demers L; Perrault A; Moride Y
    Clin Ther; 2002 Jun; 24(6):862-86; discussion 837. PubMed ID: 12117079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive function.
    van Rooden S; Buijs M; van Vliet ME; Versluis MJ; Webb AG; Oleksik AM; van de Wiel L; Middelkoop HA; Blauw GJ; Weverling-Rynsburger AW; Goos JD; van der Flier WM; Koene T; Scheltens P; Barkhof F; van de Rest O; Slagboom PE; van Buchem MA; van der Grond J
    NMR Biomed; 2016 Sep; 29(9):1289-94. PubMed ID: 25522735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial.
    Park KW; Kim EJ; Han HJ; Shim YS; Kwon JC; Ku BD; Park KH; Yi HA; Kim KK; Yang DW; Lee HW; Kang H; Kwon OD; Kim S; Lee JH; Chung EJ; Park SW; Park MY; Yoon B; Kim BC; Seo SW; Choi SH
    PLoS One; 2017; 12(8):e0182123. PubMed ID: 28786987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity and Reliability Study of Online Cognitive Tracking Software (BEYNEX).
    Çınar N; Aslan Kendirli S; Florentina Ateş M; Yakupoğlu E; Akbuğa E; Bolu NE; Karalı FS; Okluoğlu T; Bülbül NG; Bayindir E; Atam KT; Hisarlı E; Akgönül S; Bagatır O; Sahiner E; Orgen B; Sahiner TAH
    J Alzheimers Dis Rep; 2024; 8(1):163-171. PubMed ID: 38405342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
    Jia J; Ji Y; Feng T; Ye Q; Peng D; Kuang W; Ning Y; Liang Z; Fan D; Wei W; Li Y; Xiao S
    J Alzheimers Dis; 2019; 72(4):1313-1322. PubMed ID: 31744005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.